Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

GRFS

Grifols SA ADR

Apr 25 • 04:00PM ET

6.27

Dollar change -0.12
Percentage change -1.88	%

Healthcare • Drug Manufacturers - General • Spain • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Index	-	P/E	25.00	EPS (ttm)	0.25	Insider Own	0.06%	Shs Outstand	256.91M	Perf Week	-4.13%
Market Cap	1.61B	Forward P/E	5.23	EPS next Y	1.20	Insider Trans	0.00%	Shs Float	256.76M	Perf Month	-3.24%
Income	170.26M	PEG	0.77	EPS next Q	-	Inst Own	48.43%	Short Float	2.57%	Perf Quarter	-17.82%
Sales	7.11B	P/S	0.23	EPS this Y	142.46%	Inst Trans	-0.02%	Short Ratio	3.06	Perf Half Y	-22.40%
Book/sh	9.48	P/B	0.66	EPS next Y	37.69%	ROA	0.27%	Short Interest	6.60M	Perf Year	-13.04%
Cash/sh	2.28	P/C	2.75	EPS next 5Y	32.40%	ROE	0.99%	52W Range	5.30 - 12.15	Perf YTD	-45.76%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-37.97%	ROI	1.02%	52W High	-48.39%	Beta	0.56
Dividend TTM	-	Quick Ratio	1.29	Sales past 5Y	6.28%	Gross Margin	38.05%	52W Low	18.30%	ATR (14)	0.32
Dividend Ex-Date	Jun 03, 2021	Current Ratio	2.79	EPS Y/Y TTM	-23.44%	Oper. Margin	13.06%	RSI (14)	41.32	Volatility	2.89% 3.45%
Employees	23744	Debt/Eq	1.74	Sales Y/Y TTM	15.91%	Profit Margin	2.40%	Recom	2.00	Target Price	14.92
Option/Short	Yes / Yes	LT Debt/Eq	1.58	EPS Q/Q	-37.36%	Payout	0.00%	Rel Volume	0.47	Prev Close	6.39
Sales Surprise	-6.10%	EPS Surprise	-26.24%	Sales Q/Q	15.89%	Earnings	Nov 02 BMO	Avg Volume	2.16M	Price	6.27
SMA20	-6.54%	SMA50	-11.03%	SMA200	-28.49%	Trades		Volume	1,012,213	Change	-1.88%

Date	Action	Analyst	Rating Change
Mar-12-24	Downgrade	Deutsche Bank	Hold → Sell
Apr-12-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Mar-03-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Feb-16-23	Upgrade	Barclays	Underweight → Equal Weight
Jan-18-23	Upgrade	Jefferies	Hold → Buy
Apr-08-22	Initiated	Morgan Stanley	Equal-Weight
Nov-05-21	Downgrade	Deutsche Bank	Buy → Hold
Oct-19-21	Downgrade	Barclays	Overweight → Underweight
Oct-06-21	Upgrade	Citigroup	Neutral → Buy
Jun-14-21	Upgrade	Deutsche Bank	Hold → Buy
Apr-20-21	Initiated	Deutsche Bank	Hold
Mar-23-21	Upgrade	Credit Suisse	Neutral → Outperform
Mar-11-21	Upgrade	HSBC Securities	Hold → Buy
Oct-01-20	Upgrade	Citigroup	Sell → Neutral
Jun-09-20	Upgrade	HSBC Securities	Reduce → Hold
Jun-09-20	Downgrade	Citigroup	Neutral → Sell
Mar-25-20	Downgrade	Citigroup	Buy → Neutral
Jun-27-19	Upgrade	JP Morgan	Neutral → Overweight
Feb-08-19	Downgrade	Berenberg	Buy → Hold
Oct-11-18	Upgrade	Berenberg	Hold → Buy

Show Previous Ratings

Apr-19-24 04:42PM	Grifols 2023 Annual Report on Form 20-F filed with the SEC (PR Newswire)
Apr-18-24 09:30AM	Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C. (GlobeNewswire)
Apr-14-24 07:16AM	Spanish drug maker Grifols will bring in independent directors, chairman tells newspaper (Reuters)
Apr-10-24 04:01AM	Grifols Plans First Bond Sale Since Short Seller Attack (Bloomberg)
Apr-04-24 04:00AM	Grifols Procleix ArboPlex Assay Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening (GlobeNewswire)
02:11PM	Loading…
Mar-29-24 02:11PM	Grifols S.A. (GRFS ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another Critical Report Hagens Berman (GlobeNewswire)
Mar-25-24 01:25PM	Grifols S.A. (GRFS ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another Critical Report Hagens Berman (GlobeNewswire)
Mar-22-24 08:03AM	Grifols Drops as Regulator Finds Relevant Deficiencies (Bloomberg) -8.26%
Mar-20-24 01:21PM	Grifols S.A. (GRFS ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another Critical Report Hagens Berman (GlobeNewswire)
Mar-08-24 06:25PM	Analyst Report: Grifols, S.A. (Morningstar Research) +24.78%
12:34PM	Health Care Roundup: Market Talk (The Wall Street Journal)
05:06AM	UPDATE 2-Europe's STOXX 600 logs weekly gains, US jobs data in focus (Reuters)
Mar-06-24 06:29PM	Analyst Report: Grifols, S.A. (Morningstar Research) -11.35%
03:21PM	Spanish Healthcare Firm Grifols Hit With New Gotham City's Short Report, Faces Questions Regarding Transparency, Integrity, Ethical Conduct (Benzinga)
Feb-29-24 03:51PM	Analyst Report: Grifols, S.A. (Morningstar Research) -19.59%
02:04PM	Loading…
02:04PM	Grifols Drops 35% as Management Flags Risk of Zero Cash Flow (Bloomberg)
Feb-21-24 11:32AM	Activists Load Up on Temenos, Grifols After Short Seller Reports (Bloomberg)
Feb-14-24 03:16AM	Grifols announces positive topline phase 3 fibrinogen clinical trial results (GlobeNewswire)
Feb-12-24 11:56AM	Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report Hagens Berman (GlobeNewswire)
07:03AM	Charles Brandes Adjusts Position in Grifols SA (GuruFocus.com)
07:03AM	Charles Brandes Bolsters Position in Grifols SA (GuruFocus.com)
Feb-08-24 01:02PM	Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report Hagens Berman (GlobeNewswire)
Feb-05-24 09:55AM	Here's Why Grifols (GRFS) Is a Great 'Buy the Bottom' Stock Now (Zacks)
Feb-01-24 08:05PM	Grifols S.A.: Company Investigated by the Portnoy Law Firm (GlobeNewswire)
10:15AM	Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report Hagens Berman (GlobeNewswire)
Jan-26-24 02:49PM	UPDATE 1-Spain's Grifols sues Gotham City fund, JV over damaging report (Reuters)
02:01PM	Grifols Sues Gotham City Over False Short-Seller Report (Bloomberg)
01:03PM	Spain's Grifols sues Gotham City fund, JV over damaging report (Reuters)
Jan-25-24 12:24PM	Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report Hagens Berman (GlobeNewswire)
Jan-23-24 05:05PM	Health Care Roundup: Market Talk (The Wall Street Journal)
12:32PM	Loading…
Jan-19-24 12:32PM	Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report Hagens Berman (GlobeNewswire)
Jan-18-24 08:36AM	ECB Asks Banks for Details About Exposure to Spains Grifols (Bloomberg)
Jan-17-24 05:44AM	Grifols Analyst Breaks Ranks With Peers After Short Seller Chaos (Bloomberg) -7.50%
Jan-16-24 05:39PM	Grifols S.A. (GRFS) Plummets After Gotham City Research Questions Accounting Hagens Berman (GlobeNewswire)
Jan-15-24 09:35AM	Here's Why Grifols (GRFS) is Poised for a Turnaround After Losing -31.55% in 4 Weeks (Zacks)
Jan-14-24 03:16PM	Grifols Says Haier Has Offered Reassurance on China Deal (Bloomberg)
03:06PM	Grifols says Haier Group still OK to buy stake in Shanghai RAAS (Reuters)
Jan-12-24 12:16PM	Grifols shares suffer worst week on record after short-seller report (Reuters) -11.68%
11:37AM	Grifols S.A. (GRFS) Plummets After Gotham City Research Questions Accounting Hagens Berman (GlobeNewswire)
05:22AM	Grifols Set for Biggest Weekly Drop Ever on Short Seller Tumult (Bloomberg)
Jan-11-24 11:49AM	Gotham Allegations False, Grifols CEO Tells Investors (Bloomberg) -13.95%
08:57AM	Grifols sees China stake sale going ahead despite Gotham City report (Reuters)
06:17AM	Grifols Faces Scrutiny of Billionaire Familys Control (Bloomberg)
Jan-10-24 10:59AM	Gotham Slashes Grifols Short Position on Same Day as Selloff (Bloomberg) +6.32%
07:01AM	Short Seller Attack Adds to Billionaire Grifols Dynasty Pain (Bloomberg)
05:24AM	Spain's Grifols to sue short-seller over critical report, shares jump (Reuters)
Jan-09-24 07:44PM	PRESS DIGEST- Financial Times - Jan. 10 (Reuters) -21.83%
02:19PM	Factbox-What does the Gotham City report say about Grifols? (Reuters)
01:18PM	Grifols S.A. (GRFS) Plummets After Gotham City Research Questions Accounting Hagens Berman (GlobeNewswire)
01:07PM	Analyst Report: Grifols, S.A. (Morningstar Research)
12:22PM	Grifols Denies Gotham Claims as Short Seller Triggers 26% Rout (Bloomberg)
11:53AM	Factbox-What is Grifols and why have its shares slumped? (Reuters)
11:24AM	10 Things to Know as Gotham City Slams Grifols (GRFS) Stock in New Short Report (InvestorPlace)
11:07AM	Grifols Stock Tanks, Short Seller Alleges Profit Manipulation, Concerning Financial Health (Benzinga)
09:47AM	Grifols S.A. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm (GlobeNewswire)
08:55AM	Grifols Sinks as Short Seller Gotham Criticizes Accounting (Bloomberg)
08:52AM	Why Is Grifols (GRFS) Stock Down 38% Today? (InvestorPlace)
05:00AM	Spain's Grifols slumps after short-seller accuses healthcare group of fraud (Investing.com)
02:22AM	Gotham City accounting queries wipe $3 billion off Grifols value (Reuters)
Jan-08-24 11:50AM	Analyst Report: Grifols, S.A. (Morningstar Research)
Dec-29-23 09:41AM	Uber and Lyft downgraded: Wall Street's top analyst calls (The Fly) +9.89%
Dec-14-23 06:30PM	Analyst Report: Grifols, S.A. (Morningstar Research)
12:00PM	Are You Looking for a Top Momentum Pick? Why Grifols (GRFS) is a Great Choice (Zacks)
Dec-12-23 08:00AM	GigaGen Receives FDA Clearance of IND to Begin Phase 1 Trial of Oncology Drug Candidate, GIGA-564, in Solid Tumors (GlobeNewswire)
Nov-16-23 05:00AM	Grifols launches new solution to facilitate pre-transfusion compatibility testing in multiple myeloma patients (PR Newswire)
Nov-15-23 08:00AM	Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous Dosing Option for Patients with Alpha1-Antitrypsin Deficiency (GlobeNewswire)
Nov-06-23 08:00AM	GigaGen Presents IND-Enabling Data and Phase 1 Trial Strategy for its Novel Anti-CTLA-4 Oncology Drug Candidate, GIGA-564, at SITC 2023 (GlobeNewswire)
Nov-03-23 04:07PM	Analyst Report: Grifols, S.A. (Morningstar Research)
02:56PM	Grifols, S.A. (NASDAQ:GRFS) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-24-23 06:30PM	Araclon Biotech Presents Positive Final Results from Phase 2 Clinical Study of ABvac40 Alzheimer's Vaccine at CTAD (GlobeNewswire)
Oct-19-23 08:00AM	GigaGen Granted Expansion of Contract with US Department of Defense to Develop Synthetic Human Antibody Treatments for Botulinum Neurotoxins (GlobeNewswire)
Sep-28-23 08:00AM	GigaGen Partners with the National Cancer Institute to Advance Oncology Drug Candidate GIGA-564 (GlobeNewswire)
Sep-14-23 11:40AM	GRFS or STVN: Which Is the Better Value Stock Right Now? (Zacks)
Sep-12-23 12:00PM	Grifols (GRFS) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks) +5.55%
09:40AM	Should Value Investors Buy Grifols (GRFS) Stock? (Zacks)
Aug-22-23 06:25PM	Analyst Report: Grifols, S.A. (Morningstar Research)
Aug-01-23 08:00AM	Grifols Accelerates Healthcare Innovation with Google Clouds AI and Analytics (GlobeNewswire) -5.96%
Jul-31-23 06:50PM	Analyst Report: Grifols, S.A. (Morningstar Research)
Jul-28-23 07:44PM	Analyst Report: Grifols, S.A. (Morningstar Research) +6.00%
Jul-21-23 09:40AM	Should Value Investors Buy Grifols (GRFS) Stock? (Zacks)
Jul-20-23 08:15AM	Grifols Achieves Positive Topline Results From Phase 4 Study of XEMBIFY® (immune globulin subcutaneous human-klhw) Evaluating Biweekly Dosing Option for Patients (GlobeNewswire)
Jul-18-23 08:00AM	Grifols Completes Enrollment in Phase 3 Study of Long-term Albutein® (albumin-human injection) Therapy for Patients with Decompensated Cirrhosis (GlobeNewswire)
Jul-13-23 08:00AM	Grifols Meets Enrollment Target in Phase 3 Study of Two Dose Regimens of Prolastin®-C in Patients with Emphysema Due to Alpha-1-Antitrypsin Deficiency (GlobeNewswire)
Jun-14-23 04:56AM	Grifols shares soar on possible sale of $1.5 billion stake in Shanghai RAAS (Reuters)
May-11-23 08:30AM	Grifols Launches AlphaID At Home, Enabling U.S. Consumers to Self-Screen for Genetic COPD (GlobeNewswire)
May-09-23 05:17PM	Analyst Report: Grifols, S.A. (Morningstar Research) +10.45%
03:39PM	Why Shares of Grifols Were Up Tuesday (Motley Fool)
Apr-18-23 10:30AM	Grifols 2022 Annual Report on Form 20-F filed with the SEC on April 18, 2023 (PR Newswire)
Mar-31-23 10:15PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Mar-27-23 11:15AM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Mar-26-23 08:45AM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Mar-15-23 09:40AM	Are Investors Undervaluing Grifols (GRFS) Right Now? (Zacks)
Mar-07-23 06:31PM	Analyst Report: Grifols, S.A. (Morningstar Research)
12:00PM	Grifols (GRFS) Upgraded to Strong Buy: Here's Why (Zacks)
Mar-06-23 07:00AM	Selagine Enters into a Collaborative Agreement with Grifols for Development and Commercialization of Immunoglobulin Eye Drops for Treating Dry Eye Disease (PR Newswire)
Feb-28-23 07:16PM	Analyst Report: Grifols, S.A. (Morningstar Research) -5.77%
03:23AM	UPDATE 2-Grifols' shares tank 10% as 2023 outlook disappoints (Reuters)
Feb-27-23 09:40AM	Is Grifols (GRFS) Stock Undervalued Right Now? (Zacks)
Feb-17-23 05:07PM	Spanish drug company with Bay Area operations to shed 2,300 jobs (American City Business Journals)
Feb-15-23 12:22PM	Grifols to lay off 8.5% of workforce under $427 mln savings plan (Reuters) +9.87%

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by Jose Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Open in Screener

SUPN

Supernus Pharmaceuticals Inc

Apr 25 • 04:00PM ET

29.31

Dollar change -0.95
Percentage change -3.14	%

Healthcare • Drug Manufacturers - Specialty & Generic • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

SUPN Supernus Pharmaceuticals Inc daily Stock Chart

Held by: IJR VTI VB IWM VBR VXF IWO IJS PJP DFAT

Index	RUT	P/E	-	EPS (ttm)	-0.00	Insider Own	4.28%	Shs Outstand	54.72M	Perf Week	1.52%
Market Cap	1.60B	Forward P/E	15.06	EPS next Y	1.95	Insider Trans	-4.84%	Shs Float	52.39M	Perf Month	-9.76%
Income	1.32M	PEG	-	EPS next Q	0.26	Inst Own	106.64%	Short Float	8.94%	Perf Quarter	1.59%
Sales	607.52M	P/S	2.64	EPS this Y	-30.39%	Inst Trans	1.11%	Short Ratio	12.04	Perf Half Y	22.12%
Book/sh	16.84	P/B	1.74	EPS next Y	18.94%	ROA	0.08%	Short Interest	4.68M	Perf Year	-21.63%
Cash/sh	4.66	P/C	6.29	EPS next 5Y	1.69%	ROE	0.15%	52W Range	21.99 - 38.09	Perf YTD	1.28%
Dividend Est.	-	P/FCF	14.51	EPS past 5Y	-59.02%	ROI	0.14%	52W High	-23.05%	Beta	1.01
Dividend TTM	-	Quick Ratio	1.43	Sales past 5Y	9.22%	Gross Margin	72.24%	52W Low	33.29%	ATR (14)	1.23
Dividend Ex-Date	-	Current Ratio	1.70	EPS Y/Y TTM	-97.75%	Oper. Margin	2.21%	RSI (14)	39.24	Volatility	3.92% 3.79%
Employees	652	Debt/Eq	0.05	Sales Y/Y TTM	-8.95%	Profit Margin	0.22%	Recom	1.50	Target Price	40.50
Option/Short	Yes / Yes	LT Debt/Eq	0.04	EPS Q/Q	-94.81%	Payout	0.00%	Rel Volume	0.90	Prev Close	30.26
Sales Surprise	5.99%	EPS Surprise	59.50%	Sales Q/Q	-1.80%	Earnings	Feb 27 AMC	Avg Volume	388.76K	Price	29.31
SMA20	-6.81%	SMA50	-6.38%	SMA200	0.77%	Trades		Volume	351,460	Change	-3.14%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-03-23	Resumed	Jefferies	Buy	$44 → $45
Dec-01-21	Resumed	Jefferies	Buy	$40 → $44
Apr-13-21	Upgrade	Jefferies	Hold → Buy	$25 → $40
Jun-16-20	Upgrade	Piper Sandler	Neutral → Overweight	$25 → $31
Jun-15-20	Resumed	Jefferies	Hold	$24
Nov-08-19	Downgrade	Berenberg	Buy → Hold
Nov-07-19	Downgrade	Stifel	Buy → Hold	$55 → $23
Nov-06-19	Downgrade	Jefferies	Buy → Hold	$46 → $23
Nov-12-18	Reiterated	B. Riley FBR	Buy	$68 → $65
Jan-18-18	Reiterated	B. Riley FBR, Inc.	Buy	$54
Dec-28-17	Reiterated	B. Riley FBR, Inc.	Buy	$50 → $54
Dec-04-17	Upgrade	Janney	Neutral → Buy
Nov-08-17	Upgrade	Stifel	Hold → Buy	$47
Oct-19-17	Initiated	FBR & Co.	Buy	$53
Sep-19-17	Downgrade	Stifel	Buy → Hold	$47
Jul-17-17	Downgrade	Piper Jaffray	Overweight → Neutral
Jul-14-17	Initiated	Janney	Neutral
Jun-01-17	Upgrade	Piper Jaffray	Neutral → Overweight
Jul-18-16	Downgrade	Piper Jaffray	Overweight → Neutral
Jul-18-16	Downgrade	Northland Capital	Outperform → Market Perform

Show Previous Ratings

Apr-24-24 04:05PM	Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024 (GlobeNewswire)
Apr-08-24 12:11PM	Supernus Pharmaceuticals Faces Second FDA Rejection For Investigational Device For Parkinson's Disease (Benzinga) -6.32%
08:00AM	Supernus Provides Regulatory Update for SPN-830 (GlobeNewswire)
Mar-27-24 04:37PM	Corporate Insiders Are Selling These 10 Small-Cap Stocks (Insider Monkey)
Mar-06-24 04:30PM	Supernus to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
08:28PM	Loading…
Mar-04-24 08:28PM	11 Best Small Cap Pharma Stocks to Invest In (Insider Monkey)
Feb-28-24 04:30PM	Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference (GlobeNewswire)
09:19AM	Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2023 Earnings Call Transcript (Insider Monkey)
07:17AM	Q4 2023 Supernus Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-27-24 07:30PM	Supernus (SUPN) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
06:50PM	Supernus Pharmaceuticals (SUPN) Lags Q4 Earnings Estimates (Zacks)
06:02PM	Supernus: Q4 Earnings Snapshot (Associated Press Finance)
05:00PM	Supernus Pharmaceuticals Inc (SUPN) Reports Robust Growth in Key Products for Full Year 2023 (GuruFocus.com)
04:05PM	Supernus Announces Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-26-24 09:15AM	Ahead of Supernus (SUPN) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
10:00AM	Loading…
Feb-20-24 10:00AM	Analysts Estimate Supernus Pharmaceuticals (SUPN) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-13-24 04:05PM	Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 27, 2024 (GlobeNewswire)
Feb-05-24 08:30AM	Supernus Wins Infringement and Validity Case on Trokendi XR against Torrent (GlobeNewswire)
Dec-19-23 07:30AM	Knight Therapeutics Enters into Exclusive License Agreement with Supernus Pharmaceuticals for Qelbree (viloxazine) in Canada (GlobeNewswire)
Dec-14-23 07:43PM	Mind-Bending Growth: 3 Psychedelic Stocks With Trippy Potential (InvestorPlace)
Nov-18-23 05:03AM	Insider Sell Alert: Director Frederick Hudson Sells 9,093 Shares of Supernus Pharmaceuticals ... (GuruFocus.com)
Nov-10-23 12:10PM	Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 09:54AM	Q3 2023 Supernus Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) +11.14%
Nov-08-23 07:30PM	Supernus (SUPN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
07:15PM	Supernus Pharmaceuticals (SUPN) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
06:08PM	Supernus: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Supernus Announces Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-07-23 04:30PM	Supernus to Participate in the Jefferies London Healthcare Conference (GlobeNewswire)
Nov-02-23 07:00AM	Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA (GlobeNewswire)
Nov-01-23 10:01AM	Supernus Pharmaceuticals (SUPN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
04:15PM	Loading…
Oct-25-23 04:15PM	Supernus Pharmaceuticals to Announce Third Quarter 2023 Financial Results and Host Conference Call on November 8, 2023 (GlobeNewswire)
Oct-16-23 05:34PM	Jay Glazer Teams Up with Supernus Pharmaceuticals to Raise Awareness of ADHD and his Qelbree® Journey (GlobeNewswire)
Oct-09-23 04:45PM	Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device (GlobeNewswire)
Sep-27-23 04:15PM	Supernus Pharmaceuticals Announces Webcast of R&D Day to be Held on October 18, 2023 in New York City (GlobeNewswire)
Sep-26-23 07:37PM	Supernus Pharmaceuticals (SUPN): A Hidden Gem in the Market? A Comprehensive Analysis of Its ... (GuruFocus.com)
Sep-09-23 08:00PM	Supernus Announces New Qelbree® Data Showing Improvement in ADHD Symptoms (GlobeNewswire)
Aug-31-23 05:30PM	Supernus to Participate in the Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-21-23 09:00AM	Bethany L. Sensenig Joins Supernus Board of Directors (GlobeNewswire)
Aug-08-23 08:30PM	Compared to Estimates, Supernus (SUPN) Q2 Earnings: A Look at Key Metrics (Zacks)
07:55PM	Supernus Pharmaceuticals (SUPN) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
06:40PM	Supernus: Q2 Earnings Snapshot (AP Finance)
04:17PM	Supernus Announces Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-28-23 02:56PM	10 Best Small Cap Pharma Stocks to Buy (Insider Monkey)
Jul-25-23 06:36AM	Does The Market Have A Low Tolerance For Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) Mixed Fundamentals? (Simply Wall St.)
Jul-24-23 04:05PM	Supernus Pharmaceuticals to Announce Second Quarter 2023 Financial Results and Host Conference Call on August 8, 2023 (GlobeNewswire)
Jun-27-23 11:50AM	The five-year shareholder returns and company earnings persist lower as Supernus Pharmaceuticals (NASDAQ:SUPN) stock falls a further 9.4% in past week (Simply Wall St.)
Jun-21-23 08:00PM	SUPN: What does Argus have to say about SUPN? (Argus Research)
Jun-10-23 07:40AM	Despite 1 Major Headwind and Pricey Shares, This Stock Is Still a Buy (Motley Fool)
May-31-23 04:15PM	Supernus to Participate in the Jefferies Healthcare Conference (GlobeNewswire)
May-11-23 08:39AM	Top Healthcare Stocks for May 2023 (Investopedia)
May-10-23 11:23AM	Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q1 2023 Earnings Call Transcript (Insider Monkey)
May-09-23 08:30PM	Supernus (SUPN) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
07:05PM	Supernus Pharmaceuticals (SUPN) Q1 Earnings and Revenues Beat Estimates (Zacks)
06:09PM	Supernus: Q1 Earnings Snapshot (AP Finance)
04:05PM	Supernus Announces First Quarter 2023 Financial Results (GlobeNewswire)
May-02-23 04:05PM	Supernus to Present at the Bank of America 2023 Health Care Conference (GlobeNewswire)
Apr-26-23 08:00PM	SUPN: What does Argus have to say about SUPN? (Argus Research)
Apr-25-23 04:15PM	Supernus Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call on May 9, 2023 (GlobeNewswire)
Apr-03-23 04:05PM	Supernus Announces Repayment of Convertible Notes (GlobeNewswire)
Mar-31-23 12:41PM	Top Small-Cap Stocks for April 2023 (Investopedia)
Mar-30-23 05:22PM	Top Healthcare Stocks for April 2023 (Investopedia)
Mar-08-23 04:05PM	Supernus to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Mar-02-23 08:29PM	Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-01-23 04:55PM	Supernus to Present at the Cowen 43rd Annual Health Care Conference (GlobeNewswire)
05:50AM	Q4 2022 Supernus Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-28-23 05:25PM	Supernus Pharmaceuticals (SUPN) Q4 Earnings and Revenues Lag Estimates (Zacks)
04:05PM	Supernus Announces Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Feb-21-23 10:00AM	Supernus Pharmaceuticals (SUPN) Earnings Expected to Grow: Should You Buy? (Zacks)
Feb-14-23 04:30PM	Supernus Enters Into $150 Million Credit Facility (GlobeNewswire)
09:27AM	Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock? (Simply Wall St.)
Feb-09-23 06:15PM	Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on February 28, 2023 (GlobeNewswire)
Jan-18-23 08:11AM	Supernus Pharmaceuticals (NASDAQ:SUPN) investors are up 3.6% in the past week, but earnings have declined over the last three years (Simply Wall St.)
Jan-03-23 07:11AM	Heres Why Supernus Pharmaceuticals (SUPN) Outperformed in Q3 (Insider Monkey) +5.05%
Dec-30-22 12:46AM	Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q3 2022 Earnings Call Transcript (Insider Monkey)
Dec-01-22 02:37PM	Supernus Pharma's Charts Are Looking Super (TheStreet.com)
Nov-22-22 05:00PM	Supernus to Present at the Piper Sandler 34th Annual Healthcare Conference (GlobeNewswire)
Nov-11-22 05:52AM	Supernus Pharmaceuticals Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
Nov-08-22 07:25PM	Supernus Pharmaceuticals (SUPN) Misses Q3 Earnings Estimates (Zacks)
05:30PM	Supernus to Present at Two November Healthcare Conferences (GlobeNewswire)
04:05PM	Supernus Announces Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-25-22 04:30PM	Supernus Pharmaceuticals to Announce Third Quarter 2022 Financial Results and Host Conference Call on November 8, 2022 (GlobeNewswire)
Oct-10-22 08:30AM	Supernus Provides Regulatory Update on SPN-830 (GlobeNewswire)
Sep-07-22 09:03AM	Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? (Simply Wall St.)
Aug-31-22 04:00PM	Supernus to Present at the 2022 Wells Fargo Healthcare Conference (GlobeNewswire)
08:55AM	Supernus Pharmaceuticals Appears Ready for an Upside Breakout (TheStreet.com)
Aug-11-22 08:59AM	The past five years for Supernus Pharmaceuticals (NASDAQ:SUPN) investors has not been profitable (Simply Wall St.)
Aug-08-22 10:00AM	Best Momentum Stocks to Buy for August 8th (Zacks)
Aug-04-22 05:25PM	Supernus Pharmaceuticals (SUPN) Q2 Earnings Lag Estimates (Zacks)
04:01PM	Supernus Announces Second Quarter 2022 Financial Results (GlobeNewswire)
Jul-25-22 05:00PM	Supernus Pharmaceuticals to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 4, 2022 (GlobeNewswire)
Jul-11-22 11:45AM	2 Small-Cap Stocks With Large-Cap Potential (Motley Fool)
Jun-02-22 04:05PM	Supernus to Participate in the Jefferies Healthcare Conference (GlobeNewswire)
May-09-22 04:05PM	Supernus Announces First Quarter 2022 Financial Results (GlobeNewswire)
May-02-22 04:55PM	Supernus Pharmaceuticals to Announce First Quarter 2022 Financial Results and Host Conference Call on May 9, 2022 (GlobeNewswire)
03:08PM	This MoCo biotechs ADHD drug just earned FDA approval this time, for adults (American City Business Journals)
08:30AM	Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults (PR Newswire)
Apr-29-22 08:00PM	Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults (GlobeNewswire)
Apr-13-22 04:11PM	Supernus Reports Final Audited Fourth Quarter and Full Year 2021 Financial Results (GlobeNewswire)
Apr-07-22 03:18PM	Supernus Pharmaceuticals Stock Sees Relative Strength Rating Jump To 92 (Investor's Business Daily)
Apr-04-22 05:00PM	Supernus Provides Update on Filing of Annual Report and Reiterates Full Year 2022 Financial Guidance (GlobeNewswire)

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bhatt Padmanabh P.	Sr. VP of IP, CSO	Mar 21 '24	Option Exercise	25.30	14,491	366,622	23,061	Mar 25 05:00 PM
Bhatt Padmanabh P.	Sr. VP of IP, CSO	Mar 21 '24	Sale	35.31	14,491	511,677	8,570	Mar 25 05:00 PM
Bhatt Padmanabh P.	Sr. VP of IP, CSO	Mar 20 '24	Option Exercise	25.30	400	10,120	8,970	Mar 22 05:00 PM
Bhatt Padmanabh P.	Sr. VP of IP, CSO	Mar 20 '24	Sale	35.31	400	14,124	8,570	Mar 22 05:00 PM
Bhatt Padmanabh P.	Sr. VP of IP, CSO	Mar 19 '24	Option Exercise	25.30	12,364	312,809	20,934	Mar 21 05:01 PM
Bhatt Padmanabh P.	Sr. VP of IP, CSO	Mar 19 '24	Sale	35.31	12,364	436,573	8,570	Mar 21 05:01 PM
Bhatt Padmanabh P.	Sr. VP of IP, CSO	Mar 13 '24	Option Exercise	17.61	62,366	1,098,523	44,686	Mar 15 06:39 PM
Bhatt Padmanabh P.	Sr. VP of IP, CSO	Mar 13 '24	Sale	33.74	62,366	2,104,289	8,570	Mar 15 06:39 PM
Bhatt Padmanabh P.	Sr. VP of IP, CSO	Mar 12 '24	Option Exercise	12.98	3,884	50,414	12,454	Mar 14 05:00 PM
Bhatt Padmanabh P.	Sr. VP of IP, CSO	Mar 12 '24	Sale	32.99	3,884	128,133	8,570	Mar 14 05:00 PM
Khattar Jack A.	President, CEO	Feb 28 '24	Option Exercise	0.00	35,000	0	932,005	Feb 29 05:00 PM
Mottola Frank	SVP, Quality, GMP, Ops, IT	Feb 28 '24	Option Exercise	0.00	990	0	8,239	Feb 29 05:01 PM
Bhatt Padmanabh P.	Sr. VP of IP, CSO	Feb 26 '24	Option Exercise	9.13	5,000	45,650	13,570	Feb 28 05:01 PM
Bhatt Padmanabh P.	Sr. VP of IP, CSO	Feb 26 '24	Sale	30.21	5,000	151,050	8,570	Feb 28 05:01 PM
Martin Tami Tillotson	Sr. V.P., Regulatory Affairs	Jan 10 '24	Option Exercise	9.24	8,000	73,920	93,664	Jan 12 05:00 PM
Martin Tami Tillotson	Sr. V.P., Regulatory Affairs	Jan 10 '24	Sale	27.91	8,000	223,280	85,664	Jan 12 05:00 PM
Rubin Jonathan	Sr. VP, Chief Medical Officer	Dec 22 '23	Option Exercise	0.00	600	0	3,447	Dec 26 05:01 PM
Khattar Jack A.	President, CEO	Dec 22 '23	Option Exercise	0.00	25,000	0	892,463	Dec 26 05:00 PM
NEWHALL CHARLES W III	Director	Nov 16 '23	Option Exercise	9.24	7,457	68,903	119,589	Nov 20 05:00 PM
NEWHALL CHARLES W III	Director	Nov 16 '23	Sale	28.01	2,500	70,025	117,089	Nov 20 05:00 PM
Hudson Frederick M.	Director	Nov 15 '23	Option Exercise	9.24	7,457	68,903	42,324	Nov 17 05:00 PM
Hudson Frederick M.	Director	Nov 15 '23	Sale	28.50	9,093	259,150	33,231	Nov 17 05:00 PM
Mottola Frank	SVP, Quality, GMP, Ops, IT	Nov 14 '23	Option Exercise	9.24	2,000	18,480	6,791	Nov 16 05:00 PM
Mottola Frank	SVP, Quality, GMP, Ops, IT	Nov 14 '23	Sale	28.13	1,110	31,224	5,681	Nov 16 05:00 PM
DEC TIMOTHY C	Senior Vice-President & CFO	Oct 13 '23	Option Exercise	0.00	4,000	0	7,000	Oct 13 05:00 PM
Khattar Jack A.	President, CEO	Sep 07 '23	Option Exercise	0.00	35,000	0	884,267	Sep 07 05:00 PM
Bhatt Padmanabh P.	Sr. VP of IP, CSO	Sep 07 '23	Option Exercise	0.00	2,500	0	8,347	Sep 07 05:00 PM
Martin Tami Tillotson	Sr. V.P., Regulatory Affairs	Aug 30 '23	Option Exercise	23.99	8,100	194,319	93,349	Sep 01 05:00 PM
Martin Tami Tillotson	Sr. V.P., Regulatory Affairs	Aug 30 '23	Sale	32.00	8,100	259,200	85,249	Sep 01 05:00 PM
Martin Tami Tillotson	Sr. V.P., Regulatory Affairs	Aug 25 '23	Sale	31.59	5,135	162,215	85,249	Aug 29 05:00 PM
Khattar Jack A.	President, CEO	May 11 '23	Option Exercise	0.00	31,250	0	864,272	May 12 05:00 PM
DEC TIMOTHY C	Senior Vice-President & CFO	May 11 '23	Option Exercise	0.00	1,500	0	3,359	May 12 05:00 PM
Bhatt Padmanabh P.	Sr. VP of IP, CSO	May 11 '23	Option Exercise	0.00	750	0	5,497	May 12 05:00 PM

Open in Screener

TSLA

Tesla Inc

Apr 25 • 04:00PM ET

170.18

Dollar change +8.05
Percentage change 4.97	%

Consumer Cyclical • Auto Manufacturers • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO QQQ IVV VUG IWF IVW ARKK VCR VV

Index	NDX, S&P 500	P/E	43.49	EPS (ttm)	3.91	Insider Own	13.01%	Shs Outstand	3.19B	Perf Week	13.51%
Market Cap	542.70B	Forward P/E	50.45	EPS next Y	3.37	Insider Trans	-0.06%	Shs Float	2.77B	Perf Month	-4.22%
Income	13.65B	PEG	2.84	EPS next Q	0.60	Inst Own	44.61%	Short Float	3.84%	Perf Quarter	-6.82%
Sales	94.75B	P/S	5.73	EPS this Y	-19.47%	Inst Trans	1.98%	Short Ratio	1.04	Perf Half Y	-21.40%
Book/sh	20.19	P/B	8.43	EPS next Y	34.26%	ROA	13.93%	Short Interest	106.65M	Perf Year	5.92%
Cash/sh	8.54	P/C	19.93	EPS next 5Y	15.30%	ROE	24.28%	52W Range	138.80 - 299.29	Perf YTD	-31.51%
Dividend Est.	-	P/FCF	392.69	EPS past 5Y	-	ROI	19.19%	52W High	-43.14%	Beta	2.45
Dividend TTM	-	Quick Ratio	1.17	Sales past 5Y	36.73%	Gross Margin	17.78%	52W Low	22.61%	ATR (14)	8.71
Dividend Ex-Date	-	Current Ratio	1.72	EPS Y/Y TTM	14.68%	Oper. Margin	7.81%	RSI (14)	53.28	Volatility	5.24% 4.06%
Employees	140473	Debt/Eq	0.15	Sales Y/Y TTM	10.12%	Profit Margin	14.41%	Recom	2.67	Target Price	183.78
Option/Short	Yes / Yes	LT Debt/Eq	0.10	EPS Q/Q	-53.71%	Payout	0.00%	Rel Volume	1.22	Prev Close	162.13
Sales Surprise	-4.14%	EPS Surprise	-8.54%	Sales Q/Q	-8.69%	Earnings	Apr 23 AMC	Avg Volume	102.19M	Price	170.18
SMA20	3.48%	SMA50	-3.42%	SMA200	-23.73%	Trades		Volume	125,147,202	Change	4.97%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-24-24	Upgrade	BofA Securities	Neutral → Buy	$220
Apr-24-24	Reiterated	RBC Capital Mkts	Outperform	$294 → $293
Apr-18-24	Downgrade	Deutsche Bank	Buy → Hold	$189 → $123
Apr-17-24	Reiterated	Barclays	Equal Weight	$225 → $180
Apr-12-24	Reiterated	Wells Fargo	Underweight	$125 → $120
Apr-12-24	Reiterated	Citigroup	Neutral	$196 → $180
Apr-10-24	Reiterated	Piper Sandler	Overweight	$225 → $205
Apr-04-24	Reiterated	Morgan Stanley	Overweight	$320 → $310
Apr-03-24	Reiterated	Truist	Hold	$193 → $176
Apr-03-24	Reiterated	Robert W. Baird	Outperform	$300 → $280
Apr-03-24	Reiterated	JP Morgan	Underweight	$130 → $115
Apr-03-24	Reiterated	HSBC Securities	Reduce	$143 → $138
Apr-03-24	Reiterated	Deutsche Bank	Buy	$200 → $189
Mar-28-24	Reiterated	Wedbush	Outperform	$315 → $300
Mar-28-24	Reiterated	Deutsche Bank	Buy	$218 → $200
Mar-27-24	Reiterated	Citigroup	Neutral	$224 → $196
Mar-25-24	Downgrade	Mizuho	Buy → Neutral	$195
Mar-18-24	Reiterated	Goldman	Neutral	$220 → $190
Mar-13-24	Downgrade	Wells Fargo	Equal Weight → Underweight	$200 → $125
Feb-26-24	Initiated	China Renaissance	Hold

Show Previous Ratings

Today 05:09AM	Tesla's Robotaxi Ambition Is Great News for Nvidia Stock Investors (Motley Fool)
05:00AM	Tesla's Elon Musk bets on driverless, Volkswagen bets on China, EV demand roars back: Autos news roundup (Quartz)
02:09AM	Tesla Stock (NASDAQ:TSLA): Earnings Not as Good as the Reaction Suggests (TipRanks)
01:45AM	xAI, Elon Musks OpenAI rival, is closing on $6B in funding and X, his social network, is already one of its shareholders (TechCrunch)
12:08AM	Analysis-Tesla's plan for affordable cars takes page from Detroit rivals (Reuters)
12:02AM	Loading…
12:02AM	Former exec Baglino sells Tesla shares worth $181.5 million, SEC filing shows (Reuters)
Apr-25-24 11:58PM	Former exec Baglino sells Tesla shares worth $181.5 mln, SEC filing shows (Reuters)
08:03PM	Cathie Wood makes almost $100 million on battered tech stock (TheStreet)
06:19PM	Analyst Report: Tesla, Inc. (Morningstar Research)
06:16PM	Tesla Stock Rose Again. Three Reasons for the Jump. (Barrons.com)
06:02PM	Hertz Stock Plunges 19% as It Continues to Lose Money on Ill-Fated Tesla EV Plan (Investopedia)
05:56PM	13 Best Growth Stocks To Invest In For the Next 5 Years (Insider Monkey)
05:19PM	Hertz is done gambling with EVs: It took a first-quarter $195 million hit on Teslas that just keep losing value and cant sell them fast enough (Fortune)
04:38PM	Tesla Stock Has Plunged In 2024 But It's Not Getting Cheaper (Investor's Business Daily)
04:21PM	Elon Musk Admits, 'I Really Didn't Think Tesla Would Be Successful' But Says If Something Is Important, Try It Despite 'Probable Failure' (Benzinga)
04:05PM	Loading…
04:05PM	Three Reasons Why Tesla Stock Is Rallying After Q1 Earnings. Elon Musk Issues Criteria For Investors. (Investor's Business Daily)
03:50PM	Magnificent Seven Stocks: Nvidia Stock Rallies; Alphabet, Microsoft Earnings Next (Investor's Business Daily)
02:31PM	Elon Musk And Mark Zuckerberg Never Fought In The Cage, But Zuckerberg Still 'Beat' Musk By Surpassing His Net Worth For First Time In Years (Benzinga)
01:27PM	Hertz loses another $200 million from its EVs (Yahoo Finance)
12:27PM	Tesla Promises Semi Truck Production to Begin in Late 2025 (Transport Topics)
10:51AM	Billionaire investor Ron Baron: Expect Tesla's stock to go up 'huge' now (CNBC TV)
10:45AM	A Damn Hard Thing to Do: Tesla Co-Founder JB Straubel Takes on Battery Recycling (Bloomberg)
10:36AM	Hertz Reports $392 Million Loss (Transport Topics)
08:20AM	Artificial Intelligence (AI) Robots Are a $38 Billion Market, According to Goldman Sachs. Here's How the "Magnificent Seven" Are Investing in the Technology. (Motley Fool)
07:09AM	Meta and Tesla: A Tale of 2 CEOs. Why Musks AI Plan Trumps Zuckerbergs (Barrons.com)
07:05AM	Elon Musk's SpaceX could spinoff Starlink in a big IPO this year, investment adviser says (Quartz)
07:00AM	Tesla Alternatives: 3 EV Stocks Poised to Outpace Elon's Empire in the Long Term (InvestorPlace)
06:54AM	Meta and Tesla: A Tale of 2 CEOs. Why Musks AI Plan Trumps Zuckerbergs, and 5 Other Things to Know Before Markets Open. (Barrons.com)
06:35AM	Forget Tesla, GM Stock Is the Real Deal for Long-Term Investors (InvestorPlace)
05:00AM	Tesla has autonomous ride-hailing service in pipeline: what to know (Fox Business)
03:22AM	Loading…
03:22AM	China's largest auto show showcases all-electric future, local brands dominate (Reuters)
02:40AM	Tesla earnings call leaves more questions to the market (DigiTimes)
01:41AM	UPDATE 2-STMicro cuts FY revenue outlook as softer car demand weighs (Reuters)
01:02AM	Decoding Tesla Inc (TSLA): A Strategic SWOT Insight (GuruFocus.com)
12:00AM	Tesla steers back towards cheaper cars (Financial Times)
Apr-24-24 11:05PM	A brutal elimination round is reshaping the worlds biggest market for electric cars (CNN Business) +12.06%
08:28PM	UPDATE 2-LG Energy Solution to minimise capex this year due to slow EV demand (Reuters)
08:28PM	LG Energy Solution to minimise capex this year due to slow EV demand (Reuters)
08:17PM	Battery firm LG Energy Solution Q1 profit plunges on weak EV sales (Reuters)
06:18PM	Investors yank $2.2 billion from Cathie Woods once-mega popular Ark funds, even as tech skyrockets (Fortune)
05:58PM	What Analysts Are Saying as Tesla Stock Gains 12% After Earnings Miss (Investopedia)
05:46PM	Tesla and Elon Musk fans have an optimistic outlook for company's future, says WSJ's Tim Higgins (CNBC TV)
05:41PM	Tech Giants Hit in Late Hours After Metas Outlook: Markets Wrap (Bloomberg)
05:18PM	Expect 'growing pains' in the EV sector: Analyst (Yahoo Finance Video)
05:02PM	Tesla Stock Soars as Elon Musk Overshadows Current Troubles With Future Hopes (Motley Fool)
04:44PM	Indexes Mixed As Meta Crashes On Earnings; Tesla Jumps On Musk's 'Cheap Car' Target (Investor's Business Daily)
04:43PM	US STOCKS-S&P 500 ends higher as markets weigh rising yields, upbeat corporate results (Reuters)
04:43PM	S&P 500 Gains and Losses Today: Hasbro Jumps as Earnings Show Licensing Strength (Investopedia)
04:38PM	Tesla CEO Elon Musk needs robots and fast (Quartz)
04:28PM	Teslas Big Rally Drives the Nasdaq Higher (The Wall Street Journal)
04:21PM	Tesla Stock Has Best Day In 842. Elon Musk Fixed a Big Mistake in a Nick of Time. (Barrons.com)
04:21PM	Tesla Stock Had Its Best Day In Years. Elon Musk Fixed a Big Mistake in a Nick of Time. (Barrons.com)
04:11PM	Tesla driver in Seattle-area crash that killed motorcyclist told police he was using Autopilot (Associated Press Finance)
04:05PM	Tesla stock surges as EV maker will 'accelerate' the launch of cheaper cars (Yahoo Finance)
04:03PM	Tesla's robotaxi plans pressure rideshare stocks Uber, Lyft (Yahoo Finance Video)
03:49PM	Sector Update: Consumer Stocks Advance in Late Afternoon Trading (MT Newswires)
03:47PM	Tesla Rally Boosts S&P 500, Nasdaq Ahead of Meta Results (MT Newswires)
03:31PM	Stocks Waver, But Tesla Jumps As Musk Sets 'Cheap Car' Target; Trump Media Soars On This Move (Investor's Business Daily)
03:28PM	The Dow falls 70 points as a Tesla rally can't sustain the market (Quartz)
03:21PM	Here's What Analysts Expect as Biden Signs Bill That Could Ban TikTok Into Law (Investopedia)
03:12PM	Wedbush Just Cut Its Price Target on Tesla (TSLA) Stock (InvestorPlace)
02:50PM	These Stocks Are Moving the Most Today: Tesla, Humana, Biogen, Enphase, Hasbro, Teledyne, Boeing, AT&T, Meta, and More (Barrons.com)
02:47PM	Tesla Stock Jumps After Earnings: Some Key Takeaways (The Wall Street Journal)
02:41PM	Stocks Waver Before the Close (Barrons.com)
02:34PM	Uber and Lyft Stock Fall on Robotaxi Worries. That Doesnt Make Sense. (Barrons.com)
02:31PM	Tesla Rally Buoys S&P 500, Nasdaq Intraday as Investors Await Meta Results (MT Newswires)
02:25PM	Top Midday Gainers (MT Newswires)
02:11PM	Tesla Management Addressed Main Concerns Heading Into Quarterly Results, BofA Says in Upgrade (MT Newswires)
02:07PM	Tesla's growth plan may be adding 'too much hope': YouTuber (Yahoo Finance Video)
01:57PM	Democrats abandon Tesla as Musk turns right-wing influencer (The Telegraph)
01:55PM	Metas $360 Billion Rally to Collide With Lofty AI Expectations (Bloomberg)
01:53PM	Elon Musk said people shouldn't own Tesla stock if they don't support its automation efforts (Quartz)
01:44PM	Tesla's stock is up due to gross margin performance not low-cost models, says Guggenheim analyst (CNBC TV)
01:44PM	Chart of the Day: Tesla (CNBC TV)
01:34PM	Elon Musk's Tesla Sidesteps Austin In A Bold Move To De-Annex 2,100 Acres Under Controversial Texas Senate Bill (Benzinga)
01:34PM	French startup FlexAI exits stealth with $30M to ease access to AI compute (TechCrunch)
01:11PM	Top Stock Movers Now: Tesla, Hasbro, Humana, and More (Investopedia)
01:05PM	Tesla Shareholder Reportedly Seeks Court Order to Keep Musk Pay Dispute in Delaware (MT Newswires)
12:59PM	Tesla Stock Is Having Its Best Day in More Than a Year. Elon Musk Fixed a Big Mistake in a Nick of Time. (Barrons.com)
12:51PM	Tesla's cheap EV plans will likely be stuck in 'Tesla time' (Yahoo Finance Video)
12:41PM	Q1 2024 Tesla Inc Earnings Call (Thomson Reuters StreetEvents)
12:35PM	S&P 500 Earnings Growth Rests On These 5 Magnificent Seven Stocks (Investor's Business Daily)
12:28PM	Why Tesla Stock Was Soaring Today (Motley Fool)
12:18PM	Texas Instruments, Mattel rise; General Dynamics, Teledyne fall, Wednesday, 4/24/2024 (Associated Press Finance)
12:17PM	Indexes Reverse Lower In Volatile Action; Tesla Soars Despite A Low In Profits As Musk Eyes New Market (Investor's Business Daily)
12:16PM	12 Best Growth Stocks to Buy and Hold in 2024 (Insider Monkey)
12:09PM	Tesla's Musk Shows Commitment to Company's AI Efforts in Analyst Call, Morgan Stanley Says (MT Newswires)
11:44AM	Tesla skepticism remains centered on potential new models, says Bernstein's Toni Sacconaghi (CNBC TV)
11:26AM	Cleveland-Cliffs Inc. (NYSE:CLF) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:09AM	Elon Musk insists Tesla isnt a car company as sales falter (Yahoo Finance)
11:09AM	Elon Musk insists Tesla isnt a car company as car sales falter (Yahoo Finance)
11:01AM	Tesla stock drives the S&P 500 and the Nasdaq higher with Meta earnings up next (Quartz)
10:57AM	The Investment Case for Tesla (TSLA) After a Weak Q1 Show (Zacks)
10:50AM	Tesla Expects Over $350 Million in Costs Related to Job Cuts (MT Newswires)
10:50AM	Tesla Just Shared Some Spectacular News for Nvidia Stock Investors (Motley Fool)
10:48AM	Elon Musk's Big Bet: Tesla to Ramp Up AI Development with Nvidia's Powerful Chips (Benzinga)
10:44AM	UPDATE 2-Tesla shareholder seeks to bar Musk from dodging from Delaware pay ruling (Reuters)
10:43AM	Indexes Try To Keep Rally Going; Tesla Soars After Results Hit Record Low As Musk Eyes New Market (Investor's Business Daily)
10:43AM	Elon Musk discusses Tesla's plans for new affordable EV models (CNBC TV)
10:41AM	Tesla shareholder seeks to block Musk from litigating pay outside of Delaware (Reuters)

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. The company operates through Automotive and Energy Generation and Storage. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of stationary energy storage products and solar energy systems, and sale of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Baglino Andrew D	SVP Powertrain and Energy Eng.	Apr 01 '24	Option Exercise	17.22	10,500	180,810	41,730	Apr 03 08:02 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	Apr 01 '24	Sale	176.20	10,500	1,850,100	31,230	Apr 03 08:02 PM
DENHOLM ROBYN M	Director	Mar 12 '24	Option Exercise	23.17	93,705	2,171,145	108,705	Mar 14 08:03 PM
DENHOLM ROBYN M	Director	Mar 12 '24	Sale	175.44	93,705	16,439,650	15,000	Mar 14 08:03 PM
Zhu Xiaotong	SVP, Automotive	Mar 06 '24	Sale	177.11	687	121,716	63,171	Mar 07 08:06 PM
Zhu Xiaotong	SVP, Automotive	Mar 05 '24	Option Exercise	0.00	2,633	0	63,858	Mar 07 08:06 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	Feb 29 '24	Option Exercise	17.22	10,500	180,810	41,730	Mar 04 08:10 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	Feb 29 '24	Sale	204.17	10,500	2,143,785	31,230	Mar 04 08:10 PM
DENHOLM ROBYN M	Director	Feb 21 '24	Option Exercise	23.17	93,706	2,171,168	108,706	Feb 23 06:52 PM
DENHOLM ROBYN M	Director	Feb 21 '24	Sale	194.73	93,706	18,247,018	15,000	Feb 23 06:52 PM
Taneja Vaibhav	Chief Financial Officer	Dec 14 '23	Option Exercise	18.22	4,000	72,880	108,930	Dec 18 07:17 PM
Taneja Vaibhav	Chief Financial Officer	Dec 14 '23	Sale	250.00	4,000	1,000,000	104,930	Dec 18 07:17 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	Dec 06 '23	Sale	244.34	1,298	317,279	69,390	Dec 07 08:24 PM
Zhu Xiaotong	SVP, Automotive	Dec 06 '23	Sale	244.34	1,049	256,377	61,124	Dec 07 08:26 PM
Taneja Vaibhav	Chief Financial Officer	Dec 06 '23	Sale	244.34	173	42,332	104,930	Dec 07 08:16 PM
Zhu Xiaotong	SVP, Automotive	Dec 05 '23	Option Exercise	0.00	2,633	0	62,173	Dec 07 08:26 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	Dec 05 '23	Option Exercise	0.00	2,586	0	70,688	Dec 07 08:24 PM
Taneja Vaibhav	Chief Financial Officer	Dec 05 '23	Option Exercise	0.00	388	0	105,104	Dec 07 08:16 PM
Taneja Vaibhav	Chief Financial Officer	Nov 29 '23	Option Exercise	18.22	4,000	72,880	108,716	Dec 01 06:38 PM
Taneja Vaibhav	Chief Financial Officer	Nov 29 '23	Sale	250.00	4,000	1,000,000	104,716	Dec 01 06:38 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	Oct 27 '23	Option Exercise	17.22	10,500	180,810	78,602	Oct 31 06:48 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	Oct 27 '23	Sale	210.67	10,500	2,212,035	68,102	Oct 31 06:48 PM
Taneja Vaibhav	Chief Financial Officer	Oct 06 '23	Option Exercise	18.22	4,000	72,880	108,716	Oct 11 07:08 PM
Taneja Vaibhav	Chief Financial Officer	Oct 06 '23	Sale	253.98	4,000	1,015,920	104,716	Oct 11 07:08 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	Sep 27 '23	Option Exercise	17.22	10,500	180,810	78,602	Sep 29 06:49 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	Sep 27 '23	Sale	244.32	10,500	2,565,360	68,102	Sep 29 06:49 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	Sep 06 '23	Sale	249.61	1,318	328,929	68,102	Sep 07 07:29 PM
Zhu Xiaotong	SVP, Automotive	Sep 06 '23	Sale	249.62	1,065	265,779	59,540	Sep 07 07:32 PM
Taneja Vaibhav	Chief Financial Officer	Sep 06 '23	Sale	249.62	177	44,121	104,716	Sep 07 07:39 PM
Taneja Vaibhav	Chief Financial Officer	Sep 05 '23	Option Exercise	16.61	4,388	72,880	108,504	Sep 07 07:39 PM
Zhu Xiaotong	SVP, Automotive	Sep 05 '23	Option Exercise	0.00	2,633	0	60,604	Sep 07 07:32 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	Sep 05 '23	Option Exercise	0.00	2,586	0	69,420	Sep 07 07:29 PM
Taneja Vaibhav	Chief Financial Officer	Sep 05 '23	Sale	250.02	4,000	1,000,072	104,504	Sep 07 07:39 PM
Zhu Xiaotong	SVP, Automotive	Sep 01 '23	Sale	257.23	2,500	643,075	57,972	Sep 06 07:40 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	Aug 28 '23	Option Exercise	17.22	10,500	180,810	77,334	Aug 30 07:46 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	Aug 28 '23	Sale	242.53	10,500	2,546,565	66,834	Aug 30 07:46 PM
Taneja Vaibhav	CFO and CAO	Aug 04 '23	Option Exercise	18.22	4,000	72,880	108,504	Aug 08 08:01 PM
Taneja Vaibhav	CFO and CAO	Aug 04 '23	Sale	261.00	4,000	1,044,000	104,504	Aug 08 08:01 PM
Kirkhorn Zachary	Chief Financial Officer	Aug 04 '23	Sale	261.00	3,750	978,750	193,790	Aug 08 07:54 PM
Zhu Xiaotong	SVP, Automotive	Aug 01 '23	Sale	266.34	2,500	665,850	60,438	Aug 03 06:20 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	Jul 27 '23	Option Exercise	17.22	10,500	180,810	77,334	Jul 31 07:21 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	Jul 27 '23	Sale	268.23	10,500	2,816,415	66,834	Jul 31 07:21 PM
Taneja Vaibhav	Chief Accounting Officer	Jul 07 '23	Option Exercise	18.22	4,000	72,880	108,504	Jul 11 09:02 PM
Taneja Vaibhav	Chief Accounting Officer	Jul 07 '23	Sale	278.36	4,000	1,113,440	104,504	Jul 11 09:02 PM
Kirkhorn Zachary	Chief Financial Officer	Jul 05 '23	Sale	278.70	3,750	1,045,125	197,540	Jul 07 07:43 PM
Zhu Xiaotong	SVP, Automotive	Jul 03 '23	Sale	276.35	2,500	690,875	62,938	Jul 06 08:10 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	Jun 27 '23	Option Exercise	19.57	10,500	205,496	77,334	Jun 29 07:54 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	Jun 27 '23	Sale	243.13	10,500	2,552,865	66,834	Jun 29 07:54 PM
Zhu Xiaotong	SVP, Automotive	Jun 14 '23	Sale	260.00	2,500	650,000	65,438	Jun 16 07:42 PM
Taneja Vaibhav	Chief Accounting Officer	Jun 09 '23	Option Exercise	18.22	12,000	218,640	116,504	Jun 13 08:48 PM
Taneja Vaibhav	Chief Accounting Officer	Jun 09 '23	Sale	250.04	12,000	3,000,444	104,504	Jun 13 08:48 PM
Kirkhorn Zachary	Chief Financial Officer	Jun 06 '23	Sale	215.51	7,403	1,595,460	201,290	Jun 07 09:41 PM
Taneja Vaibhav	Chief Accounting Officer	Jun 06 '23	Sale	215.51	3,181	685,585	104,504	Jun 07 09:16 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	Jun 06 '23	Sale	215.51	1,298	279,837	66,834	Jun 07 08:47 PM
Zhu Xiaotong	SVP, Automotive	Jun 06 '23	Sale	215.51	794	171,006	67,938	Jun 07 08:44 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	Jun 05 '23	Option Exercise	0.00	2,586	0	68,133	Jun 07 08:47 PM
Zhu Xiaotong	SVP, Automotive	Jun 05 '23	Option Exercise	0.00	2,633	0	68,731	Jun 07 08:44 PM
Kirkhorn Zachary	Chief Financial Officer	Jun 05 '23	Option Exercise	0.00	16,871	0	208,693	Jun 07 09:41 PM
Taneja Vaibhav	Chief Accounting Officer	Jun 05 '23	Option Exercise	0.00	7,138	0	107,686	Jun 07 09:16 PM
Kirkhorn Zachary	Chief Financial Officer	Jun 05 '23	Sale	217.69	3,750	816,338	191,822	Jun 07 09:41 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	May 30 '23	Option Exercise	20.91	10,500	219,555	76,047	Jun 01 07:52 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	May 30 '23	Sale	200.00	10,500	2,100,000	65,547	Jun 01 07:52 PM
Kirkhorn Zachary	Chief Financial Officer	May 04 '23	Sale	162.70	3,751	610,247	195,572	May 08 07:48 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	Apr 27 '23	Option Exercise	20.91	10,500	219,555	76,047	May 01 07:58 PM
Baglino Andrew D	SVP Powertrain and Energy Eng.	Apr 27 '23	Sale	152.44	10,500	1,600,620	65,547	May 01 07:58 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

GRFS

Grifols SA ADR

SUPN

Supernus Pharmaceuticals Inc

TSLA

Tesla Inc

Upgrade your FINVIZ experience